1232144

Lonza Biologics, Inc. — FEI 3001451441

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 7, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Portsmouth, NH (United States)